Joshua Bartch - CEO of Mydecine Innovations Group, has a proven history as a business leader and has a successful track record in creating shareholder value. Josh has built from scratch, scaled, and successfully sold several businesses throughout his career. Mr. Bartch was a pioneer in the beginning stages of the legal cannabis industry and is skilled at working in fast growth emerging industries and in growing publicly traded companies.
Damon Michaels - COO, has been heavily involved in the cannabis industry for over the past decade. Being a strong key management member of multiple large ventures within the cannabis space, Damon has been able to gain tremendous experience within the cannabis vertical from seed-to-sale and has built a massive network of resources. Damon’s last endeavor was with a company called ebbu which was the first dedicated company to the drug discovery of cannabinoids, which ultimately was acquired by Canopy Growth for CAD$429mm. Damon has also been involved in the action sports industry and also was one of four entrepreneurs to start Colorado's first ever glass recycling facility to focus on sustainable recycling.
Nikolai Vassev - CEO of Mindleap Health, has spent the majority of his career helping organizations solve their biggest challenges with innovative technology. His interest in the breakthrough potential of psychedelic medicine led him to start Mindleap Health a company focused on providing an advanced platform for psychedelic aftercare, addiction, and holistic wellness. During his time working at high-growth technology companies, he has formed multi-million-dollar partnerships, sold and led complex data analytics and cybersecurity software projects for various Fortune 500 organizations, as well as for the US and Canadian Governments. Nikolai’s mission is to positively impact society by contributing to the broad adoption of psychedelic medicine.
Damon Michaels - COO, has been heavily involved in the cannabis industry for over the past decade. Being a strong key management member of multiple large ventures within the cannabis space, Damon has been able to gain tremendous experience within the cannabis vertical from seed-to-sale and has built a massive network of resources. Damon’s last endeavor was with a company called ebbu which was the first dedicated company to the drug discovery of cannabinoids, which ultimately was acquired by Canopy Growth for CAD$429mm. Damon has also been involved in the action sports industry and also was one of four entrepreneurs to start Colorado's first ever glass recycling facility to focus on sustainable recycling.
Colonel (Ret’d) Richard Pucci, OMM, CD, BSc, MDS, - CEO, NeuroPharm served in many command and strategic level staff positions on behalf of the Canadian Forces in Canada, the United Kingdom, United States and operational tours. He retired at the rank of Colonel while serving as the Deputy Commander of the Canadian Forces Health Services. As Deputy Commander, Col. Pucci oversaw a team of approximately 6,400 active members and 500 contractors; responsible for over-watch via the chain of command of 43 units and 82 detachments, incl. clinics, mobile medical units, field hospital, schools, research establishment, and medical equipment depot. Served as Chief of Staff of the Health Services Group, with the overall responsibility for a financial and business planning cycle of $462 million, and infrastructure budget of $600 million.
Damon Michaels - COO, has been heavily involved in the cannabis industry for over the past decade. Being a strong key management member of multiple large ventures within the cannabis space, Damon has been able to gain tremendous experience within the cannabis vertical from seed-to-sale and has built a massive network of resources. Damon’s last endeavor was with a company called ebbu which was the first dedicated company to the drug discovery of cannabinoids, which ultimately was acquired by Canopy Growth for CAD$429mm. Damon has also been involved in the action sports industry and also was one of four entrepreneurs to start Colorado's first ever glass recycling facility to focus on sustainable recycling.
Damon Michaels - COO, is a vision-driven, dynamic, goal-focused leader with a 15+ year track record of executing growth strategies, developing innovative brands and products, and delivering on operational and compliance targets. Damon has demonstrated his ability to lead teams and scale companies in fast-paced and hyper-growth environments. Damon was instrumental to the operations of ebbu, one of the leading cannabis IP companies that was acquired by Canopy Growth in November of 2018 for CAD $429 million.
Jim Gunning - CMO, has an extensive and successful background in leadership and brand building. He was one of the first hires at Red Bull North America. In his 10 years with the brand he was an instrumental figure in their path to becoming a cultural phenomenon and to their hyper successful growth. He has since consulted and/or managed significant marketing programs with a multitude of brands from Target, Vitamin Water, Mattel to Jagermeister. His true passion is working with new brands in emerging categories.
Robert Fletcher Roscow Jr. - CSO, is a biologist, entrepreneur, and inventor, who has worked extensively in the Cannabis biotech space. This work has included the filing of multiple patent applications, the sale of a start-up company and the administration of large research programs for an international publicly traded company. In addition to his scientific and business work Mr. Roscow has served as an industry stakeholder or expert for government panels on regulation in the US hemp industry.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. Vince Polito, PhD, is a researcher in the Department of Cognitive Science at Macquarie University, Australia who has focused his research on consciousness, agency and altered states. In 2019 Vince led one of the largest to date systematic studies of microdosing psychedelics where he led the research from conceptualization, data curation, formal analysis, investigation, methodology, administration and software validation. Vince’s systematic, observational investigation of individuals who microdose and has significant knowledge and expertise on the subject leads the direction of Mydecine’s research.
Anton Gomez-Escolar, MA, MSc, Psychopharmacologist, a Member of the UNAD commission on international drug policy. Advisor to large pharma and nutraceutical companies, investment firms, and government committees on public health.
Dr. Robin Carhart-Harris, PhD, Leads Imperial College London’s Centre For Psychedelic Research. Regularly publishes research on psychedelic medicines in clinical perspectives.
Dr. David Erritzoe, PhD, MD, PhD, MRCPsych, NIHR Academic Clinical Lecturer in General Psychiatry in Neuropsychopharmacology and Psychedelic Research Centres, Division of Psychiatry, Dpt of Brain Sciences, Imperial College London.
Dr. Malireddy Srinivasulu Reddy, M.S., PhD, is a seven-time Nobel prize nominee and one of the world’s most pre-eminent authorities in applied microbiology as it relates to dairy foods, probiotics, and pollution mitigation. He holds over 150 U.S. and international patents, of which more than 100 are used daily in international commerce. He has also published over 70 scientific articles and has written several best selling books, including ‘A to Z of Success: 26 Keys to Winning’.
Dr. Rakesh Jetly, OMM, CD, MD, FRCPC, is currently the Head of the Centre of Excellence on Mental Health in Ottawa, Ontario, and an associate professor of psychiatry at Dalhousie University ; Queen’s University, and the University of Ottawa. Previously Director of the “Operational Trauma and Stress Support Centre,” Atlantic Region; Chief Resident in Psychiatry, St. Michael’s Hospital; and Senior Medical Officer for the “Canadian Contingent United Nations Middle East” in ISRAEL.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. Mohyuddin Mirza, PhD, P.Ag, Botanist who brings over four decades of experience and industry knowledge to greenhouse technologies. Dr. Mirza holds a Ph.D. from the University of Alberta and served as an adjunct professor at his alma matter. Dr. Mirza was inducted into the Alberta Agriculture Hall of Fame.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. Zul Merali, PhD, Past experience includes, President/CEO and Scientific Director of the University of Ottawa Institute of Mental Health Research. His research focuses on the body's response to stressful and appetitive events and the relationship of stressors (including early-life trauma) to mood and anxiety disorders.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. Margaret McKinnon PHD, CPSYCH, Homewood Chair in Mental Health and Trauma, Associate Chair of Research, Department of Psychiatry & Behavioral Neurosciences, Associate Professor, Department of Department of Psychiatry & Behavioral Neurosciences, Psychologist, Mood Disorders Program, St Joseph’s HealthCare Psychologist, Senior Scientist, Homewood Research Institute
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. Ruth Lanius, MD, PhD, Professor of Psychiatry is the director of the posttraumatic stress disorder (PTSD) research unit at the University of Western Ontario. She established the Traumatic Stress Service and the Traumatic Stress Service Workplace Program, services that specialize in the treatment and research of Posttraumatic Stress Disorder (PTSD) and related comorbid disorders.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. Gary H. Wynn, MD, COL, MC, USA, Professor of Psychiatry and Neuroscience, Assistant Chair of the Department of Psychiatry, and Senior Scientist at the Center for the Study of Traumatic Stress. Has served as a frequent member of DoD level committees and working groups on the topics of trauma, PTSD, and suicide.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr Paul Frewen, Md Phd, Psychiatry and psychology professor at Western University. Currently chair of the Traumatic Stress Section of the Canadian Psychological Association (CPA). He has authored over 100 peer-reviewed articles on the subjects of trauma, affect regulation, mindfulness, dissociation, and the self.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. John Gustin, MD, Was responsible for introducing Garcinia Cambogia (now the number one selling dietary supplement) into the United States marketplace as a nutritional supplement and helped to conduct the first human clinical studies on Garcinia Cambogia along with the President of the American Society of Bariatricians. His discoveries have been viewed by millions on CNN, NBC, CBS, ABC and Fox News.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. Danielle Wise, PhD, 30 years of psychotherapy, therapy, and mental health coaching with clients. Significant experience with telemedicine and using psychedelic aftercare tools in her practice.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Dr. Rick Barnett, PsyD, MA, MS, LADC, Clinical psychiatrist who is an expert in addictive disorders (including sex, drugs, food, and addiction), and problems such as depression, anxiety, and relationship difficulties. Board member, Vermont Psychology Association, Founder of CARTER Inc., private nonprofit organization dedicated to the art and science of achieving lifelong freedom from addiction.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.
Prof. Dr. H.G.J.M. Eric Vermetten MD, Ph.D. Colonel, Professor of Medical-Biological and Psychiatric Aspects of Psychotrauma, LUMC/University of Leiden. Has published over 300 articles and book chapters from large longitudinal studies following soldiers’ deployments to innovative approaches to treatment.
Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.